FIELD: medicine, pharmaceutics.
SUBSTANCE: declared invention refers to chemical-pharmaceutical industry and concerns a drug which contains a portion containing an oxygen-intolerant active ingredient wherein the oxygen-intolerant active ingredient is (R)-5,6-dimethoxy-2-[2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran-5-yl]isoindoline and a sugar coating containing (1) sugar alcohol as a base material of the sugar coating where sugar alcohol is erythrite and (2) a binding agent where the binding agent is gum arabic wherein a portion is sugar-coated. Also, the invention concerns a method for preparing the declared drug.
EFFECT: agent exhibits high storage stability and oxygen tolerance.
8 cl, 18 ex, 15 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2470637C2 |
COMPOSITIONS AND METHODS OF ACTIVE PHARMACEUTICAL INGREDIENT STABILISATION | 2005 |
|
RU2391115C2 |
SOLID MEDICATION OF OLMESARTAN MEDOXOMIL AND AMLODIPINE | 2007 |
|
RU2423975C2 |
AGENT BASED ON DRY MOTHERWORT EXTRACT AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2589507C1 |
TABLET WITH ENTEROSOLUBLE COATING AND METHOD OF PREPARING | 1998 |
|
RU2201217C2 |
IRBESARTAN-CONTAINING PHARMACEUTICAL COMPOSITIONS | 2008 |
|
RU2465900C2 |
FILM-GENERATING COMPOSITION FOR APPLICATION OF COATINGS BASED ON SOLID POWDER-LIKE COMPOUNDS | 2010 |
|
RU2563133C2 |
GRANULES HAVING NUCLEUS COATED WITH ANTIFUNGAL PREPARATION AND POLYMER | 1999 |
|
RU2219909C2 |
SUGAR COATINGS AND METHODS OF THEIR APPLICATION | 2005 |
|
RU2428178C2 |
SOLID ENTERIC ORAL DOSAGE FORM OF PROINSULIN C-PEPTIDE (VERSIONS) AND METHOD FOR PREPARING IT (VERSIONS) | 2013 |
|
RU2522897C1 |
Authors
Dates
2010-12-27—Published
2006-06-09—Filed